Literature DB >> 29063280

Pulmonary Hypertension Due to Left Ventricular Cardiomyopathy: Is it the Result or Cause of Disease Progression?

Srinath Adusumalli1, Jeremy A Mazurek2,3.   

Abstract

PURPOSE OF REVIEW: The purpose of this review is to define pulmonary hypertension in the setting of left heart disease (PH-LHD), discuss its epidemiology and pathophysiology, and highlight the cause and effect relationship it has with disease progression in the setting of cardiomyopathy. RECENT
FINDINGS: Both pulmonary hypertension (PH) and heart failure are becoming increasingly common. As such, PH-LHD is now the most common form of PH. The pathophysiology of the condition relates to backward transmission of elevated left ventricular filling pressures into the pulmonary circulation and, ultimately, right ventricular (RV) strain/dysfunction. It is evident that these pathophysiologic processes are both the effect and cause of left heart disease progression. In this review, we describe the complex relationship between disease progression in left ventricular cardiomyopathy and PH-LHD. Clinicians and researchers should take note of the importance of PH-LHD and RV dysfunction to appropriately risk stratify patients and develop therapies for the condition.

Entities:  

Keywords:  Cardiomyopathy; Heart failure; Left heart disease; Pulmonary hypertension; Valvular heart disease; WHO group 2

Mesh:

Year:  2017        PMID: 29063280      PMCID: PMC5846484          DOI: 10.1007/s11897-017-0368-2

Source DB:  PubMed          Journal:  Curr Heart Fail Rep        ISSN: 1546-9530


  42 in total

1.  Pulmonary Arterial Capacitance Is an Important Predictor of Mortality in Heart Failure With a Preserved Ejection Fraction.

Authors:  Nadine Al-Naamani; Ioana R Preston; Jessica K Paulus; Nicholas S Hill; Kari E Roberts
Journal:  JACC Heart Fail       Date:  2015-06       Impact factor: 12.035

Review 2.  Pulmonary hypertension due to left heart disease.

Authors:  Marco Guazzi; Barry A Borlaug
Journal:  Circulation       Date:  2012-08-21       Impact factor: 29.690

Review 3.  Pulmonary Hypertension in Heart Failure Patients: Pathophysiology and Prognostic Implications.

Authors:  Marco Guazzi; Valentina Labate
Journal:  Curr Heart Fail Rep       Date:  2016-12

4.  Galectin-3 Levels Are Elevated and Predictive of Mortality in Pulmonary Hypertension.

Authors:  Jeremy A Mazurek; Benjamin D Horne; Wajeeha Saeed; Muhammad R Sardar; Ronald Zolty
Journal:  Heart Lung Circ       Date:  2017-02-08       Impact factor: 2.975

5.  Pulmonary capillary wedge pressure augments right ventricular pulsatile loading.

Authors:  Ryan J Tedford; Paul M Hassoun; Stephen C Mathai; Reda E Girgis; Stuart D Russell; David R Thiemann; Oscar H Cingolani; James O Mudd; Barry A Borlaug; Margaret M Redfield; David J Lederer; David A Kass
Journal:  Circulation       Date:  2011-11-30       Impact factor: 29.690

6.  The diastolic pulmonary gradient does not predict survival in patients with pulmonary hypertension due to left heart disease.

Authors:  Emmanouil Tampakakis; Peter J Leary; Van N Selby; Teresa De Marco; Thomas P Cappola; G Michael Felker; Stuart D Russell; Edward K Kasper; Ryan J Tedford
Journal:  JACC Heart Fail       Date:  2014-11-12       Impact factor: 12.035

7.  Diastolic pulmonary vascular pressure gradient: a predictor of prognosis in "out-of-proportion" pulmonary hypertension.

Authors:  Christian Gerges; Mario Gerges; Marie B Lang; Yuhui Zhang; Johannes Jakowitsch; Peter Probst; Gerald Maurer; Irene M Lang
Journal:  Chest       Date:  2013-03       Impact factor: 9.410

8.  Clinical features, hemodynamics, and outcomes of pulmonary hypertension due to chronic heart failure with reduced ejection fraction: pulmonary hypertension and heart failure.

Authors:  Wayne L Miller; Diane E Grill; Barry A Borlaug
Journal:  JACC Heart Fail       Date:  2013-08-05       Impact factor: 12.035

9.  Determinants of ventilatory efficiency in heart failure: the role of right ventricular performance and pulmonary vascular tone.

Authors:  Gregory D Lewis; Ravi V Shah; Paul P Pappagianopolas; David M Systrom; Marc J Semigran
Journal:  Circ Heart Fail       Date:  2008-11       Impact factor: 8.790

10.  Cardiac structure and function in heart failure with preserved ejection fraction: baseline findings from the echocardiographic study of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist trial.

Authors:  Amil M Shah; Sanjiv J Shah; Inder S Anand; Nancy K Sweitzer; Eileen O'Meara; John F Heitner; George Sopko; Guichu Li; Susan F Assmann; Sonja M McKinlay; Bertram Pitt; Marc A Pfeffer; Scott D Solomon
Journal:  Circ Heart Fail       Date:  2013-11-18       Impact factor: 8.790

View more
  3 in total

1.  The Impact of Spiritual Care Education on Anxiety in Family Caregivers of Patients with Heart Failure.

Authors:  Milad Borji; Seyed Rahmatollah Mousavimoghadam; Ebrahim Salimi; Masoumeh Otaghi; Yosof Azizi
Journal:  J Relig Health       Date:  2019-12

Review 2.  Pulmonary Hypertension in Advanced Heart Failure: Assessment and Management of the Failing RV and LV.

Authors:  Sriram D Rao; Jonathan N Menachem; Edo Y Birati; Jeremy A Mazurek
Journal:  Curr Heart Fail Rep       Date:  2019-10

3.  Pathophysiological Mapping of Experimental Heart Failure: Left and Right Ventricular Remodeling in Transverse Aortic Constriction Is Temporally, Kinetically and Structurally Distinct.

Authors:  Mathew J Platt; Jason S Huber; Nadya Romanova; Keith R Brunt; Jeremy A Simpson
Journal:  Front Physiol       Date:  2018-05-15       Impact factor: 4.566

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.